MLAB Biosciences Appoints Dr. Edward M. Kaye as Chair of Scientific Advisory Board

NEEDHAM, Mass., Sept. 15, 2025 /PRNewswire/ -- MLAB Biosciences, a biotechnology company pioneering novel therapies for neuromuscular disease, today announced the appointment of Edward M. Kaye, M.D., former Chief Executive Officer of Sarepta Therapeutics and Stoke Therapeutics, as Chair...